#begin document (nw/p2.5_c2e/00/p2.5_c2e_0036); part 000
nw/p2.5_c2e/00/p2.5_c2e_0036   0    0                A     DT   (TOP(S(NP(NP*         -    -   -   -   *        (ARG1*   (ARG0*             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    1            study     NN               *)        -    -   -   -   *             *)       *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    2         recently     RB       (VP(ADVP*)        -    -   -   -   *    (ARGM-TMP*)       *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    3         released    VBN               *    release  01   2   -   *           (V*)       *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    4               by     IN            (PP*         -    -   -   -   *        (ARG0*        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    5         American     JJ            (NP*         -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    6      researchers    NNS            *))))        -    -   -   -   *             *)       *)            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    7            shows    VBZ            (VP*       show  01   1   -   *             *      (V*)            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    8             that     IN          (SBAR*         -    -   -   -   *             *   (ARG1*             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    9               if     IN        (S(SBAR*         -    -   -   -   *             *        *             *    (ARGM-ADV*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   10            early     JJ  (S(NP(NML(NML*         -    -   -   -   *             *        *        (ARG0*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   11               -    HYPH               *         -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   12            stage     NN               *)        -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   13           breast     NN               *         -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   14           cancer     NN               *)        -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   15        survivors    NNS               *)        -    -   -   -   *             *        *             *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   16    intentionally     RB          (ADVP*)        -    -   -   -   *             *        *    (ARGM-MNR*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   17           reduce    VBP            (VP*     reduce  01   1   -   *             *        *           (V*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   18            their   PRP$            (NP*         -    -   -   -   *             *        *        (ARG1*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   19              fat     NN               *         -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   20           intake     NN            *))))        -    -   -   -   *             *        *             *)            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   21                ,      ,               *         -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   22             they    PRP            (NP*)        -    -   -   -   *             *        *             *        (ARG0*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   23              may     MD            (VP*         -    -   -   -   *             *        *             *    (ARGM-MOD*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   24            lower     VB            (VP*      lower  01   2   -   *             *        *             *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   25            their   PRP$         (NP(NP*         -    -   -   -   *             *        *             *        (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   26             risk     NN               *)        -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   27               of     IN            (PP*         -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   28       recurrence     NN         (NP(NP*)        -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   29               of     IN            (PP*         -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   30              the     DT            (NP*         -    -   -   -   *             *        *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   31          disease     NN      *))))))))))        -    -   -   -   *             *        *)            *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   32                .      .              *))        -    -   -   -   *             *        *             *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0036   0    0    Researchers    NNS   (TOP(S(NP(NP*)       -    -   -   -   *        (ARG0*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    1             at     IN            (PP*        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    2            the     DT      (NP(NP(NP*        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    3     University    NNP               *)       -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    4             of     IN            (PP*        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    5     California    NNP          (NP*)))       -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    6              ,      ,               *        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    7            USA    NNP         (NP*))))       -    -   -   -   *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    8              ,      ,               *        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    9       randomly     RB          (ADVP*)       -    -   -   -   *    (ARGM-MNR*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   10        divided    VBD            (VP*    divide  02   2   -   *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   11         2,437      CD            (NP*        -    -   -   -   *        (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   12          early     JJ       (NML(NML*        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   13             -    HYPH               *        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   14          stage     NN               *)       -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   15         breast     NN               *        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   16         cancer     NN               *)       -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   17          women    NNS               *        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   18       patients    NNS               *)       -    -   -   -   *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   19           into     IN            (PP*        -    -   -   -   *        (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   20          Group    NNP         (NP(NP*        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   21              A    NNP               *)       -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   22            and     CC               *        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   23          Group    NNP            (NP*        -    -   -   -   *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   24              B    NNP            *))))       -    -   -   -   *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   25              .      .              *))       -    -   -   -   *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0036   0    0                The     DT   (TOP(S(NP*         -    -   -   -   *        *       (ARG0*         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    1        researchers    NNS            *)        -    -   -   -   *        *            *)        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    2               gave    VBD         (VP*       give   -   2   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    3             people    NNS      (NP(NP*)        -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    4                 in     IN         (PP*         -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    5              Group    NNP         (NP*         -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    6                  A    NNP          *)))        -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    7            regular     JJ      (NP(NP*         -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    8            lessons    NNS            *)        -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    9              about     IN         (PP*         -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   10           reducing    VBG       (S(VP*     reduce  01   -   -   *      (V*)           *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   11                fat     NN         (NP*         -    -   -   -   *   (ARG1*            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   12             intake     NN        *)))))        -    -   -   -   *        *)           *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   13                  ,      ,            *         -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   14          requiring    VBG       (S(VP*    require  01   2   -   *        *          (V*)        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   15               them    PRP         (NP*)        -    -   -   -   *        *       (ARG2*)   (ARG0*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   16                 to     TO       (S(VP*         -    -   -   -   *        *       (ARG1*         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   17             record     VB         (VP*     record  01   1   -   *        *            *       (V*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   18              their   PRP$         (NP*         -    -   -   -   *        *            *    (ARG1*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   19              daily     JJ            *         -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   20                fat     NN            *         -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   21             intake     NN         *))))        -    -   -   -   *        *            *)        *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   22                 so     IN       (SBAR*         -    -   -   -   *        *   (ARGM-PRP*         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   23                 as     IN            *         -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   24                 to     TO       (S(VP*         -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   25               make     VB         (VP*       make   -   4   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   26               them    PRP       (S(NP*)        -    -   -   -   *        *            *         *        (ARG0*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   27    conscientiously     RB       (ADVP*)        -    -   -   -   *        *            *         *    (ARGM-MNR*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   28             reduce     VB         (VP*     reduce  01   1   -   *        *            *         *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   29              their   PRP$         (NP*         -    -   -   -   *        *            *         *        (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   30                fat     NN            *         -    -   -   -   *        *            *         *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   31             intake     NN   *))))))))))        -    -   -   -   *        *            *)        *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   32                  .      .           *))        -    -   -   -   *        *            *         *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0036   0    0            Yet    CC     (TOP(S*      -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    1            the    DT        (NP*      -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    2    researchers   NNS           *)     -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    3            did   VBD        (VP*      -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    4            not    RB           *      -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    5           make    VB        (VP*    make  -   1   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    6            any    DT     (NP(NP*      -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    7        special    JJ           *      -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    8        request    NN           *)     -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    9             to    IN        (PP*      -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   10          women   NNS     (NP(NP*)     -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   11             in    IN        (PP*      -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   12          Group   NNP        (NP*      -   -   -   -   *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   13             B.   NNP   *)))))))))     -   -   -   -   *   -

nw/p2.5_c2e/00/p2.5_c2e_0036   0    0         At    IN  (TOP(S(PP*    -    -   -   -   *   (ARGM-TMP*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    1        the    DT     (NP(NP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    2      start    NN           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    3         of    IN        (PP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    4        the    DT        (NP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    5      study    NN        *))))   -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    6          ,     ,           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    7        the    DT     (NP(NP*    -    -   -   -   *       (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    8    average    JJ           *    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    9     weight    NN           *)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   10         of    IN        (PP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   11      women   NNS     (NP(NP*)   -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   12         in    IN        (PP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   13       both    DT        (NP*    -    -   -   -   *            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   14     groups   NNS       *)))))   -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   15        was   VBD        (VP*    be  01   1   -   *          (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   16        the    DT        (NP*    -    -   -   -   *       (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   17       same    JJ          *))   -    -   -   -   *            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   18          .     .          *))   -    -   -   -   *            *   -

nw/p2.5_c2e/00/p2.5_c2e_0036   0    0            However      RB         (TOP(S(ADVP*)       -    -   -   -   *             *    (ARGM-ADV*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    1                  ,       ,                    *        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    2               five      CD            (ADVP(NP*        -    -   -   -   *             *    (ARGM-TMP*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    3              years     NNS                    *)       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    4              later      RB                    *)       -    -   -   -   *             *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    5                  ,       ,                    *        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    6            because      IN               (SBAR*        -    -   -   -   *             *    (ARGM-CAU*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    7             people     NNS            (S(NP(NP*)       -    -   -   -   *        (ARG0*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    8                 in      IN                 (PP*        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    9              Group     NNP                 (NP*        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   10                  A     NNP                  *)))       -    -   -   -   *             *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   11    conscientiously      RB               (ADVP*)       -    -   -   -   *    (ARGM-MNR*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   12            reduced     VBD                 (VP*    reduce  01   1   -   *           (V*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   13              their    PRP$                 (NP*        -    -   -   -   *        (ARG1*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   14                fat      NN                    *        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   15             intake      NN                 *))))       -    -   -   -   *             *)            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   16                  ,       ,                    *        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   17              their    PRP$                 (NP*        -    -   -   -   *             *        (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   18            average      JJ                    *        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   19         individual      JJ                    *        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   20             weight      NN                    *)       -    -   -   -   *             *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   21                was     VBD                 (VP*        be  01   2   -   *             *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   22                six      CD  (ADJP(ADJP(NML(NML*        -    -   -   -   *             *        (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   23             pounds     NNS                    *)       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   24             -LRB-   -LRB-                     *        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   25              about      RB             (NML(QP*        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   26              2.72       CD                    *)       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   27                 kg     NNS                    *)       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   28             -RRB-   -RRB-                     *)       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   29               less     JJR                    *)       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   30               than      IN                 (PP*        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   31               that      DT              (NP(NP*)       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   32                 of      IN                 (PP*        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   33             people     NNS              (NP(NP*)       -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   34                 in      IN                 (PP*        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   35              Group     NNP                 (NP*        -    -   -   -   *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   36                  B     NNP             *))))))))       -    -   -   -   *             *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   37                  .       .                   *))       -    -   -   -   *             *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0036   0    0          After     IN       (TOP(S(PP*            -    -   -   -   *        *         *            *   (ARGM-TMP*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    1     conducting    VBG           (S(VP*       conduct  01   2   -   *      (V*)        *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    2         follow     VB     (NP(NP(ADJP*        follow  03   -   -   *   (ARG1*       (V*)  (ARGM-TMP*            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    3             -    HYPH                *            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    4             up     RP                *)           -    -   -   -   *        *         *            *)           *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    5     comparison     NN                *)   comparison  01   1   -   *        *    (ARG0*)         (V*)           *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    6             of     IN             (PP*            -    -   -   -   *        *         *       (ARG1*            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    7            the     DT          (NP(NP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    8     conditions    NNS                *)           -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0    9             of     IN             (PP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   10          these     DT             (NP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   11       patients    NNS         *))))))))           -    -   -   -   *        *)        *            *)           *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   12              ,      ,                *            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   13            the     DT             (NP*            -    -   -   -   *   (ARG0*         *            *       (ARG0*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   14    researchers    NNS                *)           -    -   -   -   *        *)        *            *            *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   15          found    VBD             (VP*          find  01   1   -   *        *         *            *          (V*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   16           that     IN           (SBAR*            -    -   -   -   *        *         *            *       (ARG1*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   17            the     DT        (S(NP(NP*            -    -   -   -   *        *         *            *            *   (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   18           rate     NN                *)           -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   19             of     IN             (PP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   20         breast     NN         (NP(NML*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   21         cancer     NN                *)           -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   22     recurrence     NN               *))           -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   23            for     IN             (PP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   24         people    NNS          (NP(NP*)           -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   25             in     IN             (PP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   26          Group    NNP             (NP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   27              A    NNP            *)))))           -    -   -   -   *        *         *            *            *        *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   28            was    VBD             (VP*            be  01   1   -   *        *         *            *            *      (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   29            24      CD  (ADJP(ADJP(NML*            -    -   -   -   *        *         *            *            *   (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   30              %     NN                *)           -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   31          lower    JJR                *)           -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   32           than     IN             (PP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   33           that     DT          (NP(NP*)           -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   34             of     IN             (PP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   35            the     DT          (NP(NP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   36         people    NNS                *)           -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   37             in     IN             (PP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   38          Group    NNP             (NP*            -    -   -   -   *        *         *            *            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   39              B    NNP      *)))))))))))           -    -   -   -   *        *         *            *            *)       *)  -
nw/p2.5_c2e/00/p2.5_c2e_0036   0   40              .      .               *))           -    -   -   -   *        *         *            *            *        *   -

#end document
